Education
About Us
Working with TipRanks
Follow Us
Palvella Therapeutics (PVLA)
NASDAQ:PVLA
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 25.90M | $ 31.42M | $ 29.32M |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 29.05M | $ -17.21M |
| Operating Income | $ -14.10M | $ -11.87M | $ -43.47M | $ -51.83M | $ -33.92M |
| EBITDA | $ -13.12M | $ 18.69M | $ -18.04M | $ -43.37M | $ -31.61M |
| Net Income | $ -17.43M | $ 18.69M | $ -27.55M | $ -43.37M | $ -37.23M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 83.60M | $ 7.35M | $ 16.05M | $ 117.76M | $ 70.44M |
| Total Assets | $ 88.23M | $ 7.55M | $ 16.52M | $ 153.56M | $ 105.01M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 13.84M | $ 16.96M |
| Net Debt | $ -83.60M | $ -7.35M | $ -16.05M | $ -103.92M | $ -53.47M |
| Total Liabilities | $ 25.63M | $ 11.43M | $ 39.70M | $ 102.81M | $ 73.98M |
| Stockholders' Equity | $ 62.61M | $ -3.88M | $ -23.17M | $ 50.76M | $ 31.03M |
| Cash Flow | |||||
| Free Cash Flow | $ -10.84M | $ -13.70M | $ -14.84M | $ -8.61M | $ -48.62M |
| Operating Cash Flow | $ -10.84M | $ -13.70M | $ -14.84M | $ -7.66M | $ -45.90M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ -949.00K | $ 39.21M |
| Financing Cash Flow | $ 87.09M | $ 5.00M | $ 9.57M | $ 59.13M | $ 10.12M |